Medicine and Dentistry
Rheumatoid Arthritis
77%
Patient
59%
Combination Therapy
30%
Spontaneous Remission
23%
Severe Acute Respiratory Syndrome Coronavirus 2
23%
Synovial Membrane
23%
Diseases
18%
Therapeutic Procedure
17%
Cells
16%
Serositis
14%
Psoriatic Arthritis
14%
B Cell
12%
Biological Product
12%
Infection
11%
Biological Marker
11%
Synovitis
10%
Arthritis
10%
Inflammatory Bowel Disease
9%
Scleroderma
9%
Systemic Lupus Erythematosus
9%
COVID-19
9%
CTLA-4
8%
Bronchoalveolar Lavage Fluid
8%
Symptom
8%
Inpatient
7%
Interstitial Lung Disease
7%
Rituximab
7%
Rheumatoid Factor
7%
Analysis
7%
Joint
7%
Autoimmunity
6%
Chlordane
6%
Assessment
5%
Belimumab
5%
Interleukin-6
5%
Fatigue
5%
Myeloid Cell
5%
CD20
5%
Blood
5%
Autoantibody
5%
Immunotherapy
5%
Immunology and Microbiology
Inflammatory Arthritis
100%
Cells
25%
Inflammation
23%
Tissues
21%
Psoriatic Arthritis
19%
Biological Product
15%
Methotrexate
13%
Autoantibodies
12%
B Cell
12%
Macrophage
10%
Systemic Lupus Erythematosus
9%
CTLA-4
8%
Synovial Fluid
8%
Immunohistochemistry
8%
Synovitis
8%
Joint
8%
Inflammatory Bowel Disease
7%
Rituximab
7%
Infectious Agent
7%
Rheumatoid Factor
6%
Tumor Necrosis Factor
6%
Fibroblast
6%
Belimumab
5%
Myeloid
5%
Electric Potential
5%
Immunity
5%
HLA DRB1 Antigen
5%
Biochemistry, Genetics and Molecular Biology
T Cell
15%
CTLA-4
6%
Association
6%
Fibroblast
5%
Collagen
5%
MicroRNA
5%
HLA-DRB1
5%